Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review

The use of natural products in dermatology is increasingly being pursued due to sustainability and ecological issues, and as a possible way to improve the therapeutic outcome of chronic skin diseases, relieving the burden for both patients and healthcare systems. The legalization of cannabis by a gr...

Full description

Bibliographic Details
Main Authors:	Ana M. Martins, Ana L. Gomes, Inês Vilas Boas, Joana Marto, Helena M. Ribeiro
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Series:	Pharmaceuticals
Subjects:	<i>Cannabis sativa</i> cannabinoids CBD THC dermatological inflammatory diseases
Online Access:	https://www.mdpi.com/1424-8247/15/2/210

Similar Items

Medical Cannabis in Pediatric Oncology: Friend or Foe?
by: Megan Malach, et al.
Published: (2022-03-01)

The Effect of Harvest Date on Temporal Cannabinoid and Biomass Production in the Floral Hemp (<i>Cannabis sativa</i> L.) Cultivars BaOx and Cherry Wine
by: Eric R. Linder, et al.
Published: (2022-10-01)

Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01)

Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
by: Brishna S. Kamal, et al.
Published: (2018-10-01)

<i>Cannabis Sativa</i> Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis
by: Anca Raluca Dinu, et al.
Published: (2020-01-01)

Simultaneous Quantification of 17 Cannabinoids in Cannabis Inflorescence by Liquid Chromatography-Mass Spectrometry
by: Amitha K. Hewavitharana, et al.
Published: (2022-03-01)

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
by: Jerome Sarris, et al.
Published: (2020-01-01)

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
by: Lara Sharpe, et al.
Published: (2020-10-01)

Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L)
by: Nirit Bernstein, et al.
Published: (2019-06-01)

Cannabis and Sleep: A Systematic Review of the Effects of Cannabinoids on Sleep Disorders
by: Anna Luchowska, et al.
Published: (2023-01-01)

Buds and Bugs: A Fascinating Tale of Gut Microbiota and Cannabis in the Fight against Cancer
by: Ahmad K. Al-Khazaleh, et al.
Published: (2024-01-01)

Screening System of <i>Cannabis sativa</i> Extracts Based on Their Mitochondrial Safety Profile Using Cytochrome c Oxidase Activity as a Biomarker
by: Ekaterina Noskova, et al.
Published: (2023-01-01)

Biological Activity of <i>Cannabis sativa</i> L. Extracts Critically Depends on Solvent Polarity and Decarboxylation
by: Guillermo Moreno-Sanz, et al.
Published: (2020-10-01)

A One-Step Grafting Methodology Can Adjust Stem Morphology and Increase THCA Yield in Medicinal Cannabis
by: Sarah Jane Purdy, et al.
Published: (2022-03-01)

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
by: Zach J. Leinen, et al.
Published: (2023-09-01)

<i>Cannabis sativa</i> L.: Crop Management and Abiotic Factors That Affect Phytocannabinoid Production
by: Ingrid Trancoso, et al.
Published: (2022-06-01)

Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: A scoping review
by: Jory Longworth, et al.
Published: (2023-03-01)

Cannabis sativa L.: A New Promising Crop for Medical and Industrial Use
by: Dimitrios BILALIS, et al.
Published: (2019-11-01)

"Medical cannabis" – compendium of pharmacist’s knowledge
by: Natalia Anna Piekuś-Słomka
Published: (2020-03-01)

Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series
by: Michał Graczyk, et al.
Published: (2022-08-01)

Methods for quantification of cannabinoids: a narrative review
by: Masoumeh Pourseyed Lazarjani, et al.
Published: (2020-10-01)

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
by: Thomas R. Arkell, et al.
Published: (2023-09-01)

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial
by: Julie Schjødtz Hansen, et al.
Published: (2021-09-01)

Differentiating Cannabis Products: Drugs, Food, and Supplements
by: Arash Salehi, et al.
Published: (2022-06-01)

Features of the morphological structure of plants and biochemical properties of introduced and domestic varieties of Cannabis sativa L.
by: А. С. Полякова, et al.
Published: (2020-12-01)

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial
by: Sukpiriyagul A, et al.
Published: (2023-08-01)

Evaluating Growth, Biomass and Cannabinoid Profiles of Floral Hemp Varieties under Different Planting Dates in Organic Soils of Florida
by: Saroop S. Sandhu, et al.
Published: (2022-11-01)

Individually tailored dosage regimen of full-spectrum Cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits
by: Patrícia Soares Silva Montagner, et al.
Published: (2023-08-01)

Systematics and Botanical Characteristics of Industrial Hemp Cannabis Sativa L
by: Malgorzata Strzelczyk, et al.
Published: (2022-12-01)

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01)

Medical Cannabis in Children
by: Adi Aran, et al.
Published: (2020-01-01)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
by: Fatma Haddad, et al.
Published: (2022-05-01)

Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges
by: Alana C. Costa, et al.
Published: (2022-11-01)

Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
by: Xintian Lyu, BS, et al.
Published: (2023-01-01)

Potential effects of cannabinoids on audiovestibular function: A narrative review
by: Joaquin Guerra, et al.
Published: (2022-12-01)

<i>Cannabis sativa</i> L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment
by: Anna Stasiłowicz, et al.
Published: (2021-01-01)

<i>Cannabis sativa</i>: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
by: Jackson M. J. Oultram, et al.
Published: (2021-02-01)

Identification of Phenotypic Characteristics in Three Chemotype Categories in the Genus Cannabis
by: Dan Jin, et al.
Published: (2021-02-01)

<i>Cannabis</i>-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability
by: Francesca Baratta, et al.
Published: (2021-02-01)

<i>Cannabis</i>-Based Oral Emulsion for Medical Purposes to Meet the Needs of Patients: Formulation, Quality and Stability
by: Francesca Baratta, et al.
Published: (2022-02-01)